Tactile Systems Technology (TCMD) Net Equity Issued and Repurchased (2017 - 2023)
Tactile Systems Technology's (TCMD) quarterly Net Equity Issued and Repurchased came in at $34.6 million in Q1 2023, up 7394.59% on a QoQ basis from $462000.0 in Q4 2022.
Tactile Systems Technology (TCMD) Net Equity Issued and Repurchased (2017 - 2023) Analysis & Trends
Tactile Systems Technology (TCMD) has 7 years of Net Equity Issued and Repurchased data on file, last reported at $34.6 million in Q1 2023.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $34.6 million in Q1 2023; TTM through Dec 2023 was $34.6 million, a 2710.47% increase from a year earlier, with the FY2023 full-year figure at $34.6 million, up 2592.46% from the prior year.
- Net Equity Issued and Repurchased for Q1 2023 stood at $34.6 million, up from $462000.0 in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for TCMD reached as high as $34.6 million in Q1 2023 and fell as low as $462000.0 in Q4 2022.
- Historically, Net Equity Issued and Repurchased has averaged $7.6 million across 5 years, with a median of $1.1 million in 2020.
- Across the five-year window, Net Equity Issued and Repurchased declined 7.47% in 2019 and sank 40.0% in 2022, its largest moves.
- Year by year, Net Equity Issued and Repurchased stood at $1.2 million in 2019, then slipped by 10.66% to $1.1 million in 2020, then slipped by 28.24% to $770000.0 in 2021, then sank by 40.0% to $462000.0 in 2022, then surged by 7394.59% to $34.6 million in 2023.
- Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $34.6 million in Q1 2023, $462000.0 in Q4 2022, and $770000.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Tactile Systems Technology | 619.08 Mn | 528.88 Mn | 57.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 34.63 Mn |
| Mar 31, 2023 | 34.63 Mn |
| Dec 31, 2022 | 462,000.00 |
| Dec 31, 2022 | 462,000.00 |
| Dec 31, 2021 | 770,000.00 |
| Dec 31, 2021 | 770,000.00 |
| Dec 31, 2020 | 1.07 Mn |
| Dec 31, 2020 | 1.07 Mn |
| Dec 31, 2019 | 1.20 Mn |
| Dec 31, 2019 | 1.20 Mn |
| Dec 31, 2018 | 1.30 Mn |
| Dec 31, 2018 | 1.30 Mn |
| Dec 31, 2017 | 927,000.00 |
| Dec 31, 2017 | 927,000.00 |